Researchers developed three different computer models to predict how a hypothetical set of 10,000 patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy. They determined that giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs and improve the value of care while preserving quality of life.
Click here for original story, Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life
Source: ScienceDaily